MarketBeat Instant News Alerts 2 hours agoDycom Industries, Inc. (NYSE:DY) Stock Has Average Price Target of $502.92 According to AnalystsMarketBeatDycom Industries, Inc. (NYSE:DY - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twelve analysts that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and ten have issued a bNYSE:DYRead Dycom Industries, Inc. (NYSE:DY) Stock Has Average Price Target of $502.92 According to Analysts2 hours agoIntellia Therapeutics, Inc. (NASDAQ:NTLA) Stock Has Average Target Price of $20.72MarketBeatShares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) have been assigned a consensus rating of "Hold" from the twenty-three brokerages that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a sell rating, eight have issued a NASDAQ:NTLARead Intellia Therapeutics, Inc. (NASDAQ:NTLA) Stock Has Average Target Price of $20.722 hours agoRoyal Gold, Inc. (NASDAQ:RGLD) Stock Rated "Moderate Buy" by Sell-Side BrokeragesMarketBeatRoyal Gold, Inc. (NASDAQ:RGLD - Get Free Report) (TSE:RGL) has received an average recommendation of "Moderate Buy" from the twelve brokerages that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the NASDAQ:RGLDRead Royal Gold, Inc. (NASDAQ:RGLD) Stock Rated "Moderate Buy" by Sell-Side Brokerages2 hours agoZillow Group, Inc. (Z) - What Are Investment Firms Thinking About This Stock?MarketBeatShares of Zillow Group, Inc. (NASDAQ:Z - Get Free Report) have been assigned an average recommendation of "Hold" from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have given a hold raNASDAQ:ZRead Zillow Group, Inc. (Z) - What Are Investment Firms Thinking About This Stock?2 hours agoAgios Pharmaceuticals, Inc. (AGIO) - What Are Analysts Thinking About This Stock?MarketBeatAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four haNASDAQ:AGIORead Agios Pharmaceuticals, Inc. (AGIO) - What Are Analysts Thinking About This Stock?2 hours agoSummit Therapeutics PLC (NASDAQ:SMMT) Stock Has Average Price Target of $28.61MarketBeatSummit Therapeutics PLC (NASDAQ:SMMT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nineteen analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hNASDAQ:SMMTRead Summit Therapeutics PLC (NASDAQ:SMMT) Stock Has Average Price Target of $28.61 Trending News1Procter & Gamble AGM Backs Directors, Dividend as Shareholders Reject Proposals2Aurora Innovation (NASDAQ:AUR) Stock Bumped Down to Strong Sell by Zacks Research3Advanced Micro Devices (NASDAQ:AMD) Stock Falls 5.7% - Here's Why4Fannie Mae (OTCMKTS:FNMA) Stock Jumps 13.3% - Here's What Happened5Amazon.com (NASDAQ:AMZN) Stock Falls 1.7% - Here's What Happened6Rolls-Royce Holdings PLC (OTCMKTS:RYCEY) Shares Shorted: Short Interest Down 41.4% in September7QuantumScape (QS) Set to Announce Earnings on Wednesday8Walmart (NASDAQ:WMT) Shares Climb 3.5% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoHudbay Minerals Inc. (TSE:HBM) Stock Has Consensus Price Target of C$42.56MarketBeatTSE:HBMRead Hudbay Minerals Inc. (TSE:HBM) Stock Has Consensus Price Target of C$42.562 hours agoBeta Bionics, Inc. (NASDAQ:BBNX) Stock Has Average Target Price of $24.00MarketBeatNASDAQ:BBNXRead Beta Bionics, Inc. (NASDAQ:BBNX) Stock Has Average Target Price of $24.002 hours agoSanofi (NASDAQ:SNY) Stock Has Average Price Target of $49.50 According to BrokeragesMarketBeatNASDAQ:SNYRead Sanofi (NASDAQ:SNY) Stock Has Average Price Target of $49.50 According to Brokerages2 hours agoAlto Neuroscience, Inc. (NYSE:ANRO) Stock Has Consensus Price Target of $37.25MarketBeatNYSE:ANRORead Alto Neuroscience, Inc. (NYSE:ANRO) Stock Has Consensus Price Target of $37.252 hours agoMacroGenics, Inc. (MGNX) - What Are Brokerages Thinking About This Stock?MarketBeatNASDAQ:MGNXRead MacroGenics, Inc. (MGNX) - What Are Brokerages Thinking About This Stock?2 hours agoAmentum Holdings, Inc. (NYSE:AMTM) Stock Rated "Hold" by Wall Street BrokeragesMarketBeatNYSE:AMTMRead Amentum Holdings, Inc. (NYSE:AMTM) Stock Rated "Hold" by Wall Street Brokerages2 hours agoHormel Foods Corporation (NYSE:HRL) Stock Has Consensus Target Price of $25.43 According to AnalystsMarketBeatNYSE:HRLRead Hormel Foods Corporation (NYSE:HRL) Stock Has Consensus Target Price of $25.43 According to Analysts2 hours agoHydro One Limited (H.TO) - What Are Analysts Thinking About This Stock?MarketBeatTSE:HRead Hydro One Limited (H.TO) - What Are Analysts Thinking About This Stock?2 hours agoNFI Group Inc. (TSE:NFI) Stock Has Average Target Price of C$30.50 According to AnalystsMarketBeatTSE:NFIRead NFI Group Inc. (TSE:NFI) Stock Has Average Target Price of C$30.50 According to Analysts2 hours agoDave Inc. (DAVE) - What Are Analysts Thinking About This Stock?MarketBeatNASDAQ:DAVERead Dave Inc. (DAVE) - What Are Analysts Thinking About This Stock?2 hours agoEupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Stock Has Average Price Target of $17.80 According to AnalystsMarketBeatNASDAQ:EPRXRead Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Stock Has Average Price Target of $17.80 According to Analysts2 hours agoMcGraw Hill, Inc. (NYSE:MH) Stock Has Consensus Price Target of $17.20MarketBeatNYSE:MHRead McGraw Hill, Inc. (NYSE:MH) Stock Has Consensus Price Target of $17.202 hours agoSmith & Nephew SNATS, Inc. (SNN) - What Are Analysts Saying About This Stock?MarketBeatNYSE:SNNRead Smith & Nephew SNATS, Inc. (SNN) - What Are Analysts Saying About This Stock?2 hours agoTango Therapeutics, Inc. (NASDAQ:TNGX) Stock Has Consensus Price Target of $43.46 According to AnalystsMarketBeatNASDAQ:TNGXRead Tango Therapeutics, Inc. (NASDAQ:TNGX) Stock Has Consensus Price Target of $43.46 According to Analysts2 hours agoUniti Group Inc. (NASDAQ:UNIT) Stock Has Average Target Price of $11.47MarketBeatNASDAQ:UNITRead Uniti Group Inc. (NASDAQ:UNIT) Stock Has Average Target Price of $11.472 hours agoTheravance Biopharma, Inc. (NASDAQ:TBPH) Stock Has Average Price Target of $19.40MarketBeatNASDAQ:TBPHRead Theravance Biopharma, Inc. (NASDAQ:TBPH) Stock Has Average Price Target of $19.402 hours agoAMETEK, Inc. $AME Shares Newly Purchased by Hanson & Doremus Investment ManagementMarketBeatNYSE:AMERead AMETEK, Inc. $AME Shares Newly Purchased by Hanson & Doremus Investment Management2 hours ago21,916 Bank of America Corporation $BAC Shares Bought by Hanson & Doremus Investment ManagementMarketBeatNYSE:BACRead 21,916 Bank of America Corporation $BAC Shares Bought by Hanson & Doremus Investment Management2 hours agoHanson & Doremus Investment Management Purchases 13,156 Shares of Bank of New York Mellon Corporation $BNYMarketBeatNYSE:BNYRead Hanson & Doremus Investment Management Purchases 13,156 Shares of Bank of New York Mellon Corporation $BNY2 hours agoAtmos Energy Corporation $ATO Stake Increased by Hanson & Doremus Investment ManagementMarketBeatNYSE:ATORead Atmos Energy Corporation $ATO Stake Increased by Hanson & Doremus Investment Management2 hours agoFranklin Resources, Inc. $BEN Shares Newly Purchased by Hanson & Doremus Investment ManagementMarketBeatNYSE:BENRead Franklin Resources, Inc. $BEN Shares Newly Purchased by Hanson & Doremus Investment Management2 hours agoCardinal Health, Inc. $CAH Shares Bought by Hanson & Doremus Investment ManagementMarketBeatNYSE:CAHRead Cardinal Health, Inc. $CAH Shares Bought by Hanson & Doremus Investment Management2 hours agoHanson & Doremus Investment Management Sells 1,603 Shares of Seagate Technology Holdings PLC $STXMarketBeatNASDAQ:STXRead Hanson & Doremus Investment Management Sells 1,603 Shares of Seagate Technology Holdings PLC $STX2 hours agoTaiwan Semiconductor Manufacturing Company Ltd. $TSM Stock: Hanson & Doremus Investment Management Reduces PositionMarketBeatNYSE:TSMRead Taiwan Semiconductor Manufacturing Company Ltd. $TSM Stock: Hanson & Doremus Investment Management Reduces Position Featured Articles and Offers3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a DipBy Dan Schmidt | October 11, 2026The end may be near for these iconic stocksFrom Chaikin Analytics (Ad)Salesforce Just Got a Rare Double Upgrade—What Changed?By Jeffrey Neal Johnson | October 12, 2026Tesla Wants to Make Its Own Chips—What Could Go Wrong?By Sam Quirke | October 14, 2026A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?By Jeffrey Neal Johnson | October 13, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)ASML Can’t Keep Up With AI Demand—Why That's a Good ThingBy Thomas Hughes | October 15, 2026Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextBy Thomas Hughes | October 11, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 334 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
